Stocks and Investing
Stocks and Investing
Tue, May 21, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mark Breidenbach Maintained (ALLO) at Buy with Decreased Target to $13 on, May 21st, 2024
Mark Breidenbach of Oppenheimer, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $14 to $13 on, May 21st, 2024.
Mark has made no other calls on ALLO in the last 4 months.
There are 5 other peers that have a rating on ALLO. Out of the 5 peers that are also analyzing ALLO, 1 agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024
These are the ratings of the 4 analyists that currently disagree with Mark
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Thursday, May 16th, 2024
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy and Held Target at $17 on, Wednesday, May 15th, 2024
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $10 on, Friday, March 15th, 2024
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $8 on, Tuesday, February 27th, 2024
Contributing Sources